Navigation Links
Aspirin reduces cardiovascular risks in men and women -- but differently

Aspirin can significantly reduce the risk of cardiovascular events -- a combined endpoint including stroke, heart attack and death due to cardiovascular disease -- in both men and women, according to a new meta-analysis of more than 95,000 patients by a Duke University Medical Center cardiologist.

However, the researchers found, the major reasons for the risk reduction differed between the sexes. For men, aspirin lowered the risk of a heart attack, while in women, aspirin reduced the risk of a stroke.

The use of aspirin, however, also carries an increased risk of bleeding among both sexes, the study found. The results of the new analysis lead the researchers to recommend that all patients and physicians should discuss the benefits and drawbacks of regularly taking aspirin as a preventative measure against cardiovascular events.

"Aspirin is a drug that has been used for many years ?it is well-understood, effective, inexpensive and widely available," said Duke cardiology fellow Jeffrey Berger, M.D, first author of a paper published Jan. 18, 2006, in the Journal of the American Medical Association. He performed much of the research while at Beth Israel Medical Center, New York, under senior author cardiologist David Brown, M.D.

"This is good news because many of the past studies of the effect of aspirin in preventing cardiovascular events looked only at men, so physicians were reluctant to prescribe aspirin for women because there was little data," Berger continued. "But now, the combined data of recent trials involving women demonstrates that women can benefit just as much from aspirin therapy as men."

Berger emphasized that more healthy men and women who can tolerate aspirin should be taking the medication for the prevention of cardiovascular disease. It is estimated that fewer than five percent of the population suffers from the known gastrointestinal side effects of aspirin or are allergic to it, meaning that many more serious
'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Aspirin discovery may improve cancer treatments
2. Male circumcision reduces risk of HIV transmission from women to men
3. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
4. New miniaturised chip dramatically reduces time taken for DNA analysis
5. New processing method reduces peanut allergenicity
6. Blocking the nerve receptor EP1 in mouse models reduces brain damage caused by stroke
7. Study finds that nutritionally enhanced rice reduces iron deficiency
8. Overfishing in inland waters reduces biodiversity and threatens health
9. New gene reduces retinal degeneration in fruit flies
10. Prenatal nicotine exposure reduces breathing response of newborns...
11. Heat-shock protein vaccine reduces alveolar bone loss

Post Your Comments:
(Date:12/1/2009)... December 1, 2009: OptiNose is pleased to announce...ical study investigating the efficacy and tolerabi...for the topical treatment of chronic rhinosinusiti...ournal of the International and European Rhinologi...l polyps is a chronic disease that can significant...
(Date:12/1/2009)... This release is available in German . , Bro.... It contains loads of mitochondria, miniature po...at. In doing this, they normally generate a voltag...s energy for cellular processes. However, the mito...They go full steam ahead all the time. The energy ...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Wound Management Technologies Acquires Resorbable Orthopedics 5146 1Wound Management Technologies Acquires Resorbable Orthopedics 5146 2Wound Management Technologies Acquires Resorbable Orthopedics 5146 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 1Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 2Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 3Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 4
...ent has awarded five faculty planning grants to de... help solve the world,s urgent demands for fresh w... and well-being, yet in poor countries more than a...ies, and more than 2 billion lack basic sanitation...ichard Luthy, a professor of civil and environment...
...ther nature or nurture determines an ant,s status ...oth. , Nature (that is, the ant,s genetic makeup)...le in determining the fate of the Florida harveste...ound in many parts of the southeastern United Stat...the University of Illinois, the University of Ariz...
...dical Center immunologist and blood and marrow tra...e as the study co-chair for a new national clinica...rd blood transplants for severe sickle cell dise...ther medical institutions in the first-ever Phase ..., the Sickle Cell Unrelated Transplant (SCURT) tri...
Other Biology News:New planning grants to fund research on freshwater issues 2New planning grants to fund research on freshwater issues 3Genes and nutrition influence caste in unusual species of harvester ant 2Genes and nutrition influence caste in unusual species of harvester ant 3Children's national co-leads nationwide study of landmark sickle cell treatment 2
(Date:12/1/2009)... , iCardiac now provides ...utical companies. , Roche...nologies, Inc., a global leader in advanced cardia...ay that a top five pharmaceutical company has sele...b services. iCardiac will provide Highly Automate...
(Date:12/1/2009)... , Michael R. Drapp, a 34... formed nanoEdge™ Technologies, a business d...mpany focused on the emerging nanotechnology space...echnologies and act as a nanotechnology incubator....ecember 1, 2009 -- Michael R. Drapp , a 34-year v...
(Date:11/30/2009)... , , Cambridge, Mass November 30, 2009 An inter...Hamamatsu Photonics, and ETH Zrich have demonstrat... emitting in the invisible part of the light spect... single light beam of a well-defined wavelength. T...in applications related to remote chemical sensing...
(Date:11/30/2009)... , , BLOOMINGTON, Minn., Nov. 30 /PRNewsw...ormance medical image management software, data mi...cting with Allina Hospitals and Clinics for a new ...tion of image storage across the Allina network of...iving solution is based on the Acuo Technologies D...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3
...Revenues Up 61%, Six-Month Net Revenues Up 40%, ET...arter and 67% for Six ...% for Second Quarter and 14% for Six ... Pharmaceutical Company,(NYSE: KVa/KVb) today repo...ng revenue and earnings growth for the second quar...
...Nov. 19 Beckman Coulter,Inc. (NYSE: BEC ), a lea...ucts that simplify, automate, and innovate complex...ynor, Beckman Coulter,s director of investor,relat...y Healthcare,Conference on Wednesday, November 28,...com.com/cgi-bin/prnh/20031202/BECLOGO ) The live ...
.... 19 Advanced Instruments, Inc., of,Norwood, Mass...0% of the,shares of Mart Microbiology B.V. of The ... disclosed. Mart Microbiology manufactures and ma...systems create custom environments for anaerobic,b...en-deprived atmospheres.,Typical applications incl...
Other Biology Technology:KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 2KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 3KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 4KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 5KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 6KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 7KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 8KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 9KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 10Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference 2Advanced Instruments Acquires Mart Microbiology B.V. 2
DTT 50 l from BD Biosciences Pharmingen
pRSET-E Echo Expression Vector Kit from Invitrogen
arrayWoRxe from Applied Precision, LLC
TopSpot E non-contact microarrayer from Parallabs
Biology Products: